Increased expression of SLC2A2 correlated with advanced clinical stage and independently associated with overall survival in patients with HCC, suggesting that SLC2A2 might be considered a prognostic factor for HCC [118]. Here, SLC2A2 is linked to hepatocellular carcinoma.